Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer ...

These extra doses will bring more highly specialised work making these novel molecules to contract manufacturing ...

While Australia's therapeutic goods regulator is evaluating two new vaccines targeting the JN.1 strain of COVID-19, the ...

The company reported Health Canada authorized the use of its Spikevax KP.2 shot for those aged six months and older. Last ...

NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in ...

Jim Cramer likes Pfizer and recommends buying more stock. Six Flags is struggling, but Cramer likes First Solar and Equity ...

Doses of Moderna's updated COVID-19 vaccine are expected to begin arriving in Canada 'within days,' a spokesperson for the ...

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

Moderna's Spikevax KP.2 targets the KP.2 variant of the virus. The U.S. Food and Drug Administration has also approved the shot, as well as updated vaccines from Pfizer and BioNTech. Moderna (MRNA ...

They are Pfizer’s Comirnaty, which is also an mRNA vaccine, as well as Novavax’s protein-based vaccine. Like Moderna’s vaccine, the Pfizer vaccine under review targets the KP.2 strain.

Health Canada approved on Tuesday of the new formula of Moderna’s Covid-19 vaccine called Spinevax for use. This follows after the department directed all provinces on Sept. 1 to destroy all of their ...

"Health Canada anticipates issuing a decision regarding the Novavax and Pfizer COVID-19 vaccines over the next weeks," Maddison said. Like Moderna's vaccine, the Pfizer vaccine under review ...